✦ LIBER ✦

4502 ORAL Phase 2 study of irinotecan and cisplatin in epidermoid carcinoma of the penis (EORTC 30992)

✍ Scribed by Theodore, C.; Skoneczna, I.; Bodrogi, I.; Leahy, M.; Chester, J.; Kerst, J.M.; Collette, L.; Ven, K.; Marréaud, S.; Oliver, R.T.D.

Book ID: 123090128
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 59 KB
Volume: 5
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(07)71133-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin and irinotecan in squamous cel

Cisplatin and irinotecan in squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group

✍ Franco M Muggia; John A Blessing; Ramon McGehee; Bradley J Monk 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 96 KB

Phase I study of irinotecan (CPT-11), ci

Phase I study of irinotecan (CPT-11), cisplatin (cDDP) and radical thoracic radiation (TRT) in the treatment of locally advanced non-small cell lung carcinoma (NSCLC)

✍ Langer, C; Movsas, B; Huang, C; Millenson, M; Maiale, C; Donahue, J; Treat, J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 118 KB

Phase II study of mitomycin-C and cispla

Phase II study of mitomycin-C and cisplatin in disseminated, squamous cell carcinoma of the uterine cervix. A European Organization for Research and Treatment of Cancer (EORTC) Gynecological Cancer Group study

✍ H.C. Wagenaar; S. Pecorelli; C. Mangioni; M.E.L. van der Burg; N. Rotmensz; A. A 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 96 KB

A phase 2 study of the oral mammalian ta

A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinoma

✍ Brian M. Slomovitz; Karen H. Lu; Taren Johnston; Robert L. Coleman; Mark Munsell 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 2 views

## Abstract ## BACKGROUND: Dysregulation of phosphatase and tensin homolog (PTEN) and the gene that encodes the p110α catalytic subunit of phosphatidylinositol‐3‐kinase (PI3K), PIK3CA, are the most common mutations in endometrial carcinoma (EC). Loss of PTEN or activation of PIK3CA results in cons

O2. Phase II study of concurrent chemora

O2. Phase II study of concurrent chemoradiotherapy with capecitabine and oxaliplatin in patients with locally advanced squamous cell carcinoma of the oral cavity

✍ G.-B. Adilbaev; G. Kidirbaeva; A.-D. Savhatova; A.-O. Turesheva; D.-G. Adilbay 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Phase III Randomized Trial of Weekly Cis

Phase III Randomized Trial of Weekly Cisplatin and Irradiation Versus Cisplatin and Tirapazamine and Irradiation in Stages IB2, IIA, IIB, IIIB, and IVA Cervical Carcinoma Limited to the Pelvis: A Gynecologic Oncology Group Study

✍ DiSilvestro, P. A.; Ali, S.; Craighead, P. S.; Lucci, J. A.; Lee, Y.-C.; Cohn, D 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 166 KB